Princeton Junction, NJ, United States of America

Richard J Robb


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 1997-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Richard J. Robb: Innovating Patient-Specific Immunotherapies

Introduction

Richard J. Robb is a notable inventor based in Princeton Junction, NJ, with a significant contribution to the field of immunotherapy. He holds a total of two patents that focus on innovative approaches to treating white blood cell malignancies and assessing immune status in patients. His work reflects a commitment to harnessing scientific advancements to improve patient care.

Latest Patents

Richard's latest patents include groundbreaking innovations in the medical field. The first patent is for a patient-specific white blood cell malignancy vaccine derived from membrane-proteoliposomes. This inventive vaccine utilizes membrane components from specific white blood cells and is designed to target malignancies effectively. Additionally, the vaccine incorporates immunostimulators and exogenous lipids, making it tailored to both the patient and the malignancy in question.

His second patent outlines methods for identifying patients with altered immune statuses. This involves calculating an immune status index by comparing protein levels in patients with those in healthy individuals. The index focuses on various proteins, helping to identify immunosuppression, hyperimmunity, and autoimmunity. This invention is particularly valuable for assessing the immune status of patients undergoing organ transplants.

Career Highlights

Throughout his career, Richard J. Robb has been affiliated with notable organizations, including Biomira USA Inc. and the United States Department of Health. His career is marked by his dedication to pushing the boundaries of medical research, particularly in the realm of patient-specific treatments.

Collaborations

Richard has collaborated with esteemed professionals in the field, most notably Mircea C. Popescu and Lawrence T. Boni. These partnerships reflect his commitment to advancing research through cooperative efforts with other experts.

Conclusion

Richard J. Robb's innovative contributions to immunotherapy illustrate the potential of tailored medical solutions. With his patents focusing on patient-specific treatments and immune status assessments, he continues to influence the landscape of medical research and provide hope for patients facing complex health challenges. His work exemplifies the vital role inventors play in transforming scientific ideas into practical applications that can significantly impact healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…